Zynerba Pharmaceuticals, Inc.
SEC CIK 1621443 · ZYNE · last insider filing 2023-10-11
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Moch Kenneth I | Director | filed 2015 - 2023 |
| Kisner Daniel L | Director | filed 2015 - 2023 |
| Cooper Warren D | Director | filed 2015 - 2023 |
| Anido Armando | Director · Chairman & Chief Exec. Officer | filed 2015 - 2023 |
| Federici William J | Director | filed 2015 - 2023 |
| Butler John P. | Director | filed 2018 - 2023 |
| Stephenson Pamela | Director | filed 2019 - 2023 |
| Harrison Thomas L | Director | filed 2015 - 2018 |
| Rask Cynthia Ann | Director | filed 2015 - 2017 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Sebree Terri B | President | filed 2015 - 2023 |
| Fickenscher James E | Chief Financial Officer | filed 2016 - 2023 |
| Rosenberger Brian | VP, Commercial & Business Dev. | filed 2017 - 2023 |
| Parker Albert P | Chief Legal Officer | filed 2022 - 2023 |
| Jones Kenneth T | See Remarks | filed 2023 - 2023 |
| Hanlon Suzanne M. | Sec, VP & General Counsel | filed 2015 - 2021 |
| Baron Richard A | Chief Financial Officer | filed 2015 - 2015 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.